Cancer Institute of New Jersey (CINJ), Division of Molecular Oncology

Research Output


Association of JAK2 -V617F Mutations Detected by Solid Tumor Sequencing with Coexistent Myeloproliferative Neoplasms

Riedlinger, G., Hadigol, M., Khiabanian, H. & Ganesan, S., Feb 2019, In : JAMA Oncology. 5, 2, p. 265-267 3 p.

Research output: Contribution to journalLetter

4 Scopus citations

Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens

Severson, E. A., Riedlinger, G. M., Connelly, C. F., Vergilio, J. A., Goldfinger, M., Ramkissoon, S., Frampton, G. M., Ross, J. S., Fratella-Calabrese, A., Gay, L., Ali, S., Miller, V., Elvin, J., Hadigol, M., Hirshfield, K. M., Rodriguez-Rodriguez, L., Ganesan, S. & Khiabanian, H., May 31 2018, In : Blood. 131, 22, p. 2501-2505 5 p.

Research output: Contribution to journalLetter

16 Scopus citations

Response to crizotinib in a patient with MET-mutant papillary renal cell cancer after progression on tivantinib

Stein, M., Hirshfield, K., Zhong, H., Singer, E., Ali, S. M. & Ganesan, S., Feb 1 2015, In : European Urology. 67, 2, p. 353-354 2 p.

Research output: Contribution to journalLetter

8 Scopus citations

Further Evidence for BRCA1 Communication with the Inactive X Chromosome

Silver, D. P., Dimitrov, S. D., Feunteun, J., Gelman, R., Drapkin, R., Lu, S. D., Shestakova, E., Velmurugan, S., DeNunzio, N., Dragomir, S., Mar, J., Liu, X., Rottenberg, S., Jonkers, J., Ganesan, S. & Livingston, D. M., Mar 9 2007, In : Cell. 128, 5, p. 991-1002 12 p.

Research output: Contribution to journalLetter

59 Scopus citations